Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 9
2003 14
2004 11
2005 10
2006 5
2007 7
2008 8
2009 19
2010 14
2011 13
2012 23
2013 26
2014 19
2015 16
2016 28
2017 29
2018 19
2019 15
2020 19
2021 25
2022 23
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
Osuka S, Zhu D, Zhang Z, Li C, Stackhouse CT, Sampetrean O, Olson JJ, Gillespie GY, Saya H, Willey CD, Van Meir EG. Osuka S, et al. Among authors: saya h. J Clin Invest. 2021 Mar 15;131(6):e136098. doi: 10.1172/JCI136098. J Clin Invest. 2021. PMID: 33720050 Free PMC article.
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T. Akiyama T, et al. Among authors: saya h. Cancer Res. 2023 Mar 2;83(5):753-770. doi: 10.1158/0008-5472.CAN-22-1890. Cancer Res. 2023. PMID: 36543251
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.
Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H. Ishimoto T, et al. Among authors: saya h. Cancer Cell. 2011 Mar 8;19(3):387-400. doi: 10.1016/j.ccr.2011.01.038. Cancer Cell. 2011. PMID: 21397861 Free article.
What can metabolites tell us about gliomas?
Sampetrean O, Saya H. Sampetrean O, et al. Among authors: saya h. Neuro Oncol. 2022 Sep 1;24(9):1469-1470. doi: 10.1093/neuonc/noac128. Neuro Oncol. 2022. PMID: 35554565 Free PMC article. No abstract available.
Gene therapy using genome-edited iPS cells for targeting malignant glioma.
Tamura R, Miyoshi H, Imaizumi K, Yo M, Kase Y, Sato T, Sato M, Morimoto Y, Sampetrean O, Kohyama J, Shinozaki M, Miyawaki A, Yoshida K, Saya H, Okano H, Toda M. Tamura R, et al. Among authors: saya h. Bioeng Transl Med. 2022 Sep 10;8(5):e10406. doi: 10.1002/btm2.10406. eCollection 2023 Sep. Bioeng Transl Med. 2022. PMID: 37693056 Free PMC article.
Modeling phenotypes of malignant gliomas.
Sampetrean O, Saya H. Sampetrean O, et al. Among authors: saya h. Cancer Sci. 2018 Jan;109(1):6-14. doi: 10.1111/cas.13351. Epub 2017 Nov 15. Cancer Sci. 2018. PMID: 28796931 Free PMC article. Review.
Molecular biology of glioma.
Marumoto T, Saya H. Marumoto T, et al. Among authors: saya h. Adv Exp Med Biol. 2012;746:2-11. doi: 10.1007/978-1-4614-3146-6_1. Adv Exp Med Biol. 2012. PMID: 22639155 Review.
331 results